Goldman Sachs Reports 2025 Full Year and Fourth Quarter Earnings Results

Goldman Sachs reported strong full-year 2025 results with net revenues of $58.28 billion and net earnings of $17.18 billion (diluted EPS $51.32), and fourth-quarter revenues of $13.45 billion and net earnings of $4.62 billion (Q4 EPS $14.01). Return on average common shareholders’ equity was 15.0% for 2025 (annualized Q4 ROE 16.0%), and management highlighted substantial revenue and return improvements since its Investor Day alongside plans to deploy capital and return cash to shareholders while maintaining disciplined risk management. The results and CEO commentary underpin a constructive outlook for 2026 and are likely to influence investor positioning ahead of the firm’s public earnings call.

Analysis

Market structure: Goldman’s 2025 results and 15% ROE signal a re-acceleration of capital-markets and advisory flows, benefiting large global banks (GS, MS, JPM) and prime brokerage/ETF providers while pressuring regional lenders and loan-dependent franchises that lack trading/investment-banking exposure. Pricing power for fees and trading spreads is likely to remain elevated in a volatile market—implying outsized P&L sensitivity to market activity vs. net interest margin. Cross-asset impact: tighter bank credit spreads, modest support for risk assets and USD outperformance on capital inflows; equity implied vols for GS should compress absent macro shocks.

Risk assessment: Tail risks include a sharp market liquidity shock, a major regulatory enforcement action, or a macro recession that cuts FICC revenues by >30% — each could erase >30% of near-term EPS. Time horizons: immediate (days) — earnings replay and share re-rating; short-term (weeks/months) — Q1 seasonality and buyback signals; long-term (quarters/years) — capital deployment and ROE trajectory. Hidden dependencies: performance hinges on continued high client flow, disciplined RWA management and conservative provisioning; proprietary investment drawdowns or aggressive RWAs would materially dilute returns. Key catalysts: upcoming Q1 2026 trading season, Fed path in H1 2026, and any concrete buyback/dividend authorization.

Trade implications: Tactical overweight GS vs regional-bank exposures; favor GS equity and short-dated call structures to capture asymmetric upside into near-term catalysts while limiting downside. Implement a relative-value pair (long GS / short KRE or BAC) to play capital-markets resilience vs lending stress for 3–6 months. Use options: buy 3-month 10–15% OTM call spreads sized to risk 0.5–1% portfolio or sell covered calls 3–6 months 5% OTM if long to monetize premium.

Contrarian angles: Consensus may overestimate sustainable margin expansion; if Fed easing reduces volatility and flows fall >20% QoQ, GS earnings could revert materially. The market may underprice regulatory and RWA risk — similar to post-2007 re-rating where apparent resilience masked leverage and eventual margin compression. Unintended consequence: aggressive buybacks without RWA discipline can boost EPS short-term but increase capital constraints and downside if markets reverse.

Key Decisions for Investors

• Establish a 2–3% long position in GS within 1–2 weeks to capture momentum; plan to increase to 4–5% only if shares pull back >7% within 30 days (buy-the-dip sizing).
• Initiate a 3–6 month pair trade: long GS (2% portfolio) / short KRE (Invesco Regional Bank ETF) (2%) to express capital-markets outperformance vs lending exposure; rebalance monthly and close if spread narrows <5% absolute.
• Purchase 3-month call spreads on GS 10–15% OTM sized to risk 0.5–1% of portfolio ahead of Q1 and investor-day catalysts; alternatively, if already long, sell 3–6 month covered calls 5% OTM to collect premium.
• Rotate 2–3% from long-duration sovereigns into 2–5 year senior bank bonds (GS, JPM) to capture likely spread tightening; cap duration exposure under 5 years and limit credit exposure to top-5 global banks.
• Apply stop/trim rules: cut GS exposure by 25% if quarterly revenues miss consensus by >4% or if management guidance implies ROE <12% for 2026; add only if management commits to buybacks ≥1.5% of market cap or announces capital redeployment >$5bn.